ArticleClinical and experimental immunology2023

Tocilizumab suppresses NF-kappa B activation via toll-like receptor 9 signaling by reducing cell-free DNA in rheumatoid arthritis.

Teppei Hashimoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.